BCIQ Profiles

Company Profile Report

Broad ErbB inhibition arrests KRAS mutant cancer

Multi-ErbB inhibitors may provide a treatment option for K-Ras (KRAS)-driven lung cancer where ErbB family member EGFR1-specific therapies have failed, according to two studies published in Science Translational Medicine on

Read the full 301 word article

How to gain access

Continue reading with a
two-week free trial.